Mahmoud S. Abdallah

The Phosphodiesterase Inhibitor Pentoxifylline as a Novel Adjunct to Antidepressants in Major Depressive Disorder Patients: A Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled Trial

Sahar Mohamed El-Haggar, Mai Eissa, Tarek M. Mostafa et al. · Psychotherapy and Psychosomatics · 2018 · 60 citations

RETRACTED ARTICLE: The Antidiabetic Metformin as an Adjunct to Antidepressants in Patients with Major Depressive Disorder: A Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled Trial

Mahmoud S. Abdallah, Esraa M. Mosalam, Abdel‐Aziz A. Zidan et al. · Neurotherapeutics · 2020 · 38 citations · Full text

Diabetes Management, Psychiatry, Psychotropic Medication +13

Applying green analytical chemistry (GAC) for development of stability indicating HPLC method for determining clonazepam and its related substances in pharmaceutical formulations and calculating uncertainty

Abdallah Shalaby, Mahmoud S. Abdallah, Moataz A. Shaldam et al. · Arabian Journal of Chemistry · 2014 · 27 citations · Full text

Ich Guidelines, Related Substances, Green Chemistry +24

The AMPK modulator metformin as adjunct to methotrexate in patients with rheumatoid arthritis: A proof-of-concept, randomized, double-blind, placebo-controlled trial

Mahmoud S. Abdallah, Sumaiah J. Alarfaj, Dalia S. Saif et al. · International Immunopharmacology · 2021 · 23 citations · Full text

RETRACTED: The Potential Neuroprotective Effect of Thymoquinone on Scopolamine-Induced In Vivo Alzheimer’s Disease-like Condition: Mechanistic Insights

Hend E. Abo Mansour, Aya Ibrahim Elberri, Mai El-Sayed Ghoneim et al. · Molecules · 2023 · 19 citations · Full text